Literature DB >> 23223062

Trialing targeted therapies for autism.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23223062     DOI： 10.1038/nm.3027

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  A 'learning platform' approach to outcome measurement in fragile X syndrome: a preliminary psychometric study.

Authors:  S S Hall; J L Hammond; M Hirt; A L Reiss
Journal:  J Intellect Disabil Res       Date:  2012-04-25

Review 2.  Toward fulfilling the promise of molecular medicine in fragile X syndrome.

Authors:  Dilja D Krueger; Mark F Bear
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

3.  Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.

Authors:  Sébastien Jacquemont; Aurore Curie; Vincent des Portes; Maria Giulia Torrioli; Elizabeth Berry-Kravis; Randi J Hagerman; Feliciano J Ramos; Kim Cornish; Yunsheng He; Charles Paulding; Giovanni Neri; Fei Chen; Nouchine Hadjikhani; Danielle Martinet; Joanne Meyer; Jacques S Beckmann; Karine Delange; Amandine Brun; Gerald Bussy; Fabrizio Gasparini; Talita Hilse; Annette Floesser; Janice Branson; Graeme Bilbe; Donald Johns; Baltazar Gomez-Mancilla
Journal:  Sci Transl Med       Date:  2011-01-05       Impact factor: 17.956

4.  Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.

Authors:  Elizabeth M Berry-Kravis; David Hessl; Barbara Rathmell; Peter Zarevics; Maryann Cherubini; Karen Walton-Bowen; Yi Mu; Danh V Nguyen; Joseph Gonzalez-Heydrich; Paul P Wang; Randall L Carpenter; Mark F Bear; Randi J Hagerman
Journal:  Sci Transl Med       Date:  2012-09-19       Impact factor: 17.956

5.  Fragile X protein FMRP is required for homeostatic plasticity and regulation of synaptic strength by retinoic acid.

Authors:  Marta E Soden; Lu Chen
Journal:  J Neurosci       Date:  2010-12-15       Impact factor: 6.167

6.  Reversal of neurological defects in a mouse model of Rett syndrome.

Authors:  Jacky Guy; Jian Gan; Jim Selfridge; Stuart Cobb; Adrian Bird
Journal:  Science       Date:  2007-02-08       Impact factor: 47.728

Review 7.  The mGluR theory of fragile X mental retardation.

Authors:  Mark F Bear; Kimberly M Huber; Stephen T Warren
Journal:  Trends Neurosci       Date:  2004-07       Impact factor: 13.837

8.  Describing the brain in autism in five dimensions--magnetic resonance imaging-assisted diagnosis of autism spectrum disorder using a multiparameter classification approach.

Authors:  Christine Ecker; Andre Marquand; Janaina Mourão-Miranda; Patrick Johnston; Eileen M Daly; Michael J Brammer; Stefanos Maltezos; Clodagh M Murphy; Dene Robertson; Steven C Williams; Declan G M Murphy
Journal:  J Neurosci       Date:  2010-08-11       Impact factor: 6.167

Review 9.  Translational approaches to the biology of Autism: false dawn or a new era?

Authors:  C Ecker; W Spooren; D G M Murphy
Journal:  Mol Psychiatry       Date:  2012-07-17       Impact factor: 15.992

Review 10.  Preclinical research in Rett syndrome: setting the foundation for translational success.

Authors:  David M Katz; Joanne E Berger-Sweeney; James H Eubanks; Monica J Justice; Jeffrey L Neul; Lucas Pozzo-Miller; Mary E Blue; Diana Christian; Jacqueline N Crawley; Maurizio Giustetto; Jacky Guy; C James Howell; Miriam Kron; Sacha B Nelson; Rodney C Samaco; Laura R Schaevitz; Coryse St Hillaire-Clarke; Juan L Young; Huda Y Zoghbi; Laura A Mamounas
Journal:  Dis Model Mech       Date:  2012-11       Impact factor: 5.758
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.